S.J.H. van Deventer - Citas de Google Académico

Citado por

	Total	Desde 2014
Citas	61969	14320
Índice h	120	57
Índice i10	464	241

3600

1800

900

2700

1992199319941995199619971998199920002001200220032004200520062007200820092010201120122013201420152016201720182019200 256 300 466 698 734 1113 1306 1861 2104 2733 2913 3115 3108 3570 3416 3172 3288 3218 3029 2953 2971 2763 2688 2454 2373 2157 1881

Coautores

Marcel LeviAMC & UCLHDirección de correo verificada de amc.uva.nl
Richard N FedorakUniversity of AlbertaDirección de correo verificada de ualberta.ca
Hugo ten CateProfessor of Medicine, Maastricht University Medical CenterDirección de correo verificada de maastrichtuniversity.nl
Gijs van den BrinkProfessor of Experimental GastroenterologyDirección de correo verificada de amc.nl
P.H. ReitsmaEinthoven Laboratory for Experimental Vascular Medicine, Leiden University Medical Center, LeidenDirección de correo verificada de lumc.nl
James C H HardwickLeiden University Medical Center, Leiden, The NetherlandsDirección de correo verificada de lumc.nl
Dasja PajkrtDirección de correo verificada de amc.uva.nl
Nicole JuffermansDirección de correo verificada de amc.uva.nl
William SandbornUniversity of California San DiegoDirección de correo verificada de ucsd.edu
Marcus J. SchultzOxford Univ., Oxford; Mahidol Univ., Bangkok; UvA & AMC, AmsterdamDirección de correo verificada de amc.uva.nl
Jochen HampeTechnische Universität Dresden (TU Dresden)Dirección de correo verificada de uniklinikum-dresden.de
A van BodegravenDirección de correo verificada de amsterdamumc.nl
Ric van TolReckitt Benckiser/Mead Johnson NutritionDirección de correo verificada de rb.com
Jaap StokerProfessor of Radiology, Academic Medical center, University of AmsterdamDirección de correo verificada de amc.uva.nl
Mark CurranJanssen R&D LLCDirección de correo verificada de its.jnj.com
Michael KammDirección de correo verificada de unimelb.edu.au
martine de vosHoogleraar gastroenterologie, Universiteit GentDirección de correo verificada de ugent.be
Patrick M. BossuytUniversity of AmsterdamDirección de correo verificada de amc.nl
Florie BorelAssociate Director - Apic BioDirección de correo verificada de apic-bio.com
Daniel Gaudetecogene21 Biocluster and dept of Medicine Université de MontréalDirección de correo verificada de umontreal.ca

S.J.H. van Deventer

Leiden University Medical Center

Dirección de correo verificada de xs4all.nl - Página principal

Gene therapy inflammatory bowel disease


Título	Citado por	Año
A short-term study of chimeric monoclonal antibody cA2 to tumor necrosis factor α for Crohn's disease SR Targan, SB Hanauer, SJH Van Deventer, L Mayer, DH Present, ... New England Journal of Medicine 337 (15), 1029-1036, 1997	3594	1997
A short-term study of chimeric monoclonal antibody cA2 to tumor necrosis factor α for Crohn's disease SR Targan, SB Hanauer, SJH Van Deventer, L Mayer, DH Present, ... New England Journal of Medicine 337 (15), 1029-1036, 1997	3561	1997
Infliximab for the treatment of fistulas in patients with Crohn's disease DH Present, P Rutgeerts, S Targan, SB Hanauer, L Mayer, ... New England Journal of Medicine 340 (18), 1398-1405, 1999	2910	1999
Infliximab for the treatment of fistulas in patients with Crohn's disease DH Present, P Rutgeerts, S Targan, SB Hanauer, L Mayer, ... New England Journal of Medicine 340 (18), 1398-1405, 1999	2910	1999
Infliximab maintenance therapy for fistulizing Crohn's disease BE Sands, FH Anderson, CN Bernstein, WY Chey, BG Feagan, ... New England Journal of Medicine 350 (9), 876-885, 2004	2177	2004
Treatment of Crohn's disease with anti-tumor necrosis factor chimeric monoclonal antibody (cA2) HM Van Dullemen, SJH van Deventer, DW Hommes, HA Bijl, J Jansen, ... Gastroenterology 109 (1), 129-135, 1995	1269	1995
Association between insertion mutation in NOD2 gene and Crohn's disease in German and British populations J Hampe, A Cuthbert, PJP Croucher, MM Mirza, S Mascheretti, S Fisher, ... The Lancet 357 (9272), 1925-1928, 2001	1255	2001
Efficacy and safety of retreatment with anti–tumor necrosis factor antibody (infliximab) to maintain remission in Crohn's disease P Rutgeerts, G D'Haens, S Targan, E Vasiliauskas, SB Hanauer, ... Gastroenterology 117 (4), 761-769, 1999	1209	1999
Polyp miss rate determined by tandem colonoscopy: a systematic review JC Van Rijn, JB Reitsma, J Stoker, PM Bossuyt, SJ Van Deventer, ... The American journal of gastroenterology 101 (2), 343, 2006	1136	2006
Early combined immunosuppression or conventional management in patients with newly diagnosed Crohn's disease: an open randomised trial G D'Haens, F Baert, G Van Assche, P Caenepeel, P Vergauwe, ... The Lancet 371 (9613), 660-667, 2008	1113	2008
Experimental endotoxemia in humans: analysis of cytokine release and coagulation, fibrinolytic, and complement pathways SJ Van Deventer, HR Buller, JW Ten Cate, LA Aarden, CE Hack, A Sturk Blood 76 (12), 2520-2526, 1990	1002	1990
Natalizumab induction and maintenance therapy for Crohn's disease WJ Sandborn, JF Colombel, R Enns, BG Feagan, SB Hanauer, ... New England Journal of Medicine 353 (18), 1912-1925, 2005	880	2005
Infliximab but not etanercept induces apoptosis in lamina propria T-lymphocytes from patients with Crohn’s disease JMH Van den Brande, H Braat, GR van den Brink, HH Versteeg, ... Gastroenterology 124 (7), 1774-1785, 2003	810	2003
Endoscopic and histological healing with infliximab anti–tumor necrosis factor antibodies in Crohn's disease: A European multicenter trial G D'Haens, S Van Deventer, R Van Hogezand, D Chalmers, C Kothe, ... Gastroenterology 116 (5), 1029-1034, 1999	809	1999
Activation of coagulation after administration of tumor necrosis factor to normal subjects T van der Poll, HR Büller, H ten Cate, CH Wortel, KA Bauer, ... New England Journal of Medicine 322 (23), 1622-1627, 1990	748	1990
A phase I trial with transgenic bacteria expressing interleukin-10 in Crohn’s disease H Braat, P Rottiers, DW Hommes, N Huyghebaert, E Remaut, JP Remon, ... Clinical gastroenterology and hepatology 4 (6), 754-759, 2006	667	2006
Infliximab treatment induces apoptosis of lamina propria T lymphocytes in Crohn's disease T Ten Hove, C Van Montfrans, MP Peppelenbosch, SJH Van Deventer Gut 50 (2), 206-211, 2002	637	2002
Mucosal tumor necrosis factor-or, interleukin-1/3, and interleukin-8 production in patients with helicobacter pylori infection LA Noach, NB Bosma, J Jansen, FJ Hoek, SJH Van Deventer, GNJ Tytgat Scandinavian journal of gastroenterology 29 (5), 425-429, 1994	620	1994
Tumour necrosis factor and Crohn's disease. SJ Van Deventer Gut 40 (4), 443, 1997	567	1997
Recombinant human interleukin 10 in the treatment of patients with mild to moderately active Crohn's disease RN Fedorak, A Gangl, CO Elson, P Rutgeerts, S Schreiber, G Wild, ... Gastroenterology 119 (6), 1473-1482, 2000	561	2000

El sistema no puede realizar la operación en estos momentos. Inténtalo de nuevo más tarde.

Artículos 1–20

Citas por año

Citas duplicadas

Citas combinadas

Añadir coautoresCoautores

Subir PDF

Seguir a este autor

Citado por

Coautores